Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McKesson Is Bristol’s Number One Wholesaler In Year After Restatement

Executive Summary

McKesson has the largest share of Bristol-Myers Squibb's pharmaceutical distribution based on restated 2003 sales figures released by the company March 15

You may also be interested in...



Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch

Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law

Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch

Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law

Rx Firms Feeling Re-Patriotic As Foreign Tax Bill Moves Through Congress

Supporters of a tax change that would allow U.S. pharmaceutical companies to "repatriate" cash held by overseas affiliates appear confident that the proposal will be enacted into law this year

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel